"
Human papillomavirus
adolescents
benefits
confidence
perceptions
risk
safety
vaccination
vaccine hesitancy
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
31 12 2022
31 12 2022
Historique:
pubmed:
5
3
2022
medline:
15
4
2022
entrez:
4
3
2022
Statut:
ppublish
Résumé
Human Papillomavirus (HPV) vaccination is one of the most publicly mistrusted vaccines in Europe, with countries such as France struggling with low vaccine uptake due to parental questioning of vaccine risks and benefits. However, limited evidence exists on adolescent girls' perceptions of the risks and benefits of HPV vaccination. The aim of this qualitative study was to provide an in-depth exploration and comparison of French mothers (n = 21) and adolescent girls' (n = 36) perceptions of the risks and benefits of HPV vaccination. A thematic analysis showed that adolescent girls and mothers perceived the risks and benefits of HPV vaccination differently, with girls reporting positive and beneficial views and emotions toward vaccination and mothers expressing concerns about possible risks. Adolescent girls also reported that both perceptions and actual risks and benefits may vary from one individual to another. Vaccine safety was also understood differently, with mothers reporting a widespread view that vaccines are unsafe and focusing on controversial side effects and girls discussing short-term consequences of vaccination (e.g. pain, fever) and administration and storage issues. Strategies to improve uptake of HPV vaccination should consider and address both the mothers' and daughters' perceptions and understandings of HPV vaccination.
Identifiants
pubmed: 35240936
doi: 10.1080/21645515.2022.2036555
pmc: PMC9009901
doi:
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2036555Références
Nicotine Tob Res. 2004 Dec;6 Suppl 3:S375-80
pubmed: 15799601
J Relig Health. 2019 Dec;58(6):2196-2207
pubmed: 31352665
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
PLoS One. 2017 Mar 1;12(3):e0172310
pubmed: 28249006
Expert Rev Vaccines. 2020 Nov;19(11):1073-1083
pubmed: 33267673
J Gynecol Obstet Biol Reprod (Paris). 2012 Apr;41(2):136-44
pubmed: 22093439
Vaccine. 2017 Sep 5;35(37):4840-4850
pubmed: 28760616
Euro Surveill. 2018 Apr;23(17):
pubmed: 29717693
Am Psychol. 1994 Aug;49(8):709-24
pubmed: 8092614
Psychooncology. 2017 Aug;26(8):1070-1079
pubmed: 27643482
Expert Rev Vaccines. 2018 Nov;17(11):989-1004
pubmed: 30359151
Health Psychol. 2007 Mar;26(2):146-51
pubmed: 17385965
Vaccine. 2006 Aug 31;24 Suppl 3:S3/26-34
pubmed: 16950015
PLoS One. 2017 Aug 25;12(8):e0183725
pubmed: 28841681
BMC Public Health. 2012 Nov 27;12:1034
pubmed: 23186288
Euro Surveill. 2008 Jan 24;13(4):
pubmed: 18445398
J Adolesc Health. 2010 Apr;46(4 Suppl):S20-6
pubmed: 20307840
Hum Vaccin. 2009 Feb;5(2):105-10
pubmed: 19164939
PLoS One. 2020 Oct 22;15(10):e0234693
pubmed: 33091021
PLoS Curr. 2015 Feb 25;7:
pubmed: 25789200
Sociol Health Illn. 2019 Jul;41(6):1192-1206
pubmed: 30972804
J Behav Med. 2002 Feb;25(1):67-82
pubmed: 11845559
Vaccine. 2013 Oct 25;31(45):5243-9
pubmed: 24012565
Vaccine. 2009 Apr 21;27(18):2483-8
pubmed: 19368790
J Pediatr Psychol. 2005 Jul-Aug;30(5):425-35
pubmed: 15944170
Psychol Sci Public Interest. 2006 Sep;7(1):1-44
pubmed: 26158695
Eur J Cancer. 2009 Oct;45(15):2709-13
pubmed: 19695863
EBioMedicine. 2016 Oct;12:295-301
pubmed: 27658738
Int J Equity Health. 2015 Aug 21;14:68
pubmed: 26293806
Health Psychol. 2005 Jul;24(4S):S35-40
pubmed: 16045417
Soc Sci Med. 2020 Dec;266:113441
pubmed: 33069959
Br J Cancer. 2003 Jan 13;88(1):63-73
pubmed: 12556961